Xagenic Inc

Xagenic Inc. is a molecular diagnostics company located in the United States. Employing 44 individuals, Xagenic generates approximately $5 million in annual revenue. Xagenic specializes in developing point-of-care diagnostic platforms, aiming to enable on-demand molecular testing at the patient's bedside. Their technology platform focuses on simplifying and automating decentralized diagnostic testing, moving it outside traditional clinical laboratory settings. Currently, they are concentrating on developing infectious disease tests that deliver rapid turnaround times, providing clinically relevant results for timely treatment decisions. Xagenic's technology aims to empower clinicians with rapid diagnostic testing capabilities, enabling them to make informed treatment decisions immediately. This approach is designed to significantly improve patient care by accelerating diagnosis and treatment, ultimately contributing to reduced healthcare costs. For more information about Xagenic Inc. and their diagnostic solutions, please visit their website at xagenic.com.